Comparison of the effects of patient controlled analgesia (PCA) using dexmedetomidine and propofol during septoplasty operations: a randomized clinical trial by unknown
Comparison of the effects 
of patient controlled analgesia (PCA) 
using dexmedetomidine and propofol 
during septoplasty operations: a randomized 
clinical trial
Başak Akça1*, Ayhan Arslan2, Aysun Ankay Yılbaş1, Özgür Canbay1 and Nalan Çelebi1
Background
Septoplastical surgery to correct septum deviation can be performed under either local 
or general anesthesia. General anesthesia provides a safe airway throughout the surgery, 
a comfortable surgical procedure and eliminates the need for patient cooperation. On 
Abstract 
Introduction: Septoplastical surgery to correct septum deviation can be performed 
under either local or general anesthesia. During local anesthesia, sedation helps to 
provide minimum anxiety/discomfort. Our aim was to evaluate the effects of patient-
controlled analgesia using dexmedetomidine and propofol on sedation level, analgesic 
requirement, and patient satisfaction.
Study design: A prospective, randomized-parallel clinical study.
Methods: Fifty patients undergoing septoplastical surgery at our university hospital 
were randomized into two groups. A nasopharyngeal cotton tampon soaked in 0.25 % 
adrenaline solution was placed, and 1 mg midazolam and 1 mcg/kg fentanyl were 
applied 5 min before the injections of a surgical local anesthetic. Loading dose was 
0.5 mg/kg propofol (Group I) and 1 mcg/kg dexmedetomidine (Group II). The sedation 
was sustained by a bolus dose of 0.2 mg/kg and continuous basal infusion dose of 
0.5 mg/kg/h propofol in Group I, or by a bolus dose of 0.05 µg/kg and continuous basal 
infusion dose of 0.4 mcg/kg/h dexmedetomidine in Group II. The primary outcomes 
were patient satisfaction via patient-controlled anesthesia and analgesic demand. 
Secondary outcomes were sedation level of patients under local anesthesia.
Results: In Group II, SpO2 levels were significantly higher than in Group I. Intraopera-
tive and postoperative analgesic requirements were lower in Group II than in Group I. 
There were no statistically significant differences in patient satisfaction, hemodynamic 
parameters, nausea and vomiting between the two groups.
Conclusion: Dexmedetomidine can be used safely as an analgesic and sedation drug 
in septoplastic surgery.
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the other hand, local anesthesia has advantages of not requiring endotracheal intubation 
or mechanical ventilation. Although local anesthesia has less postoperative side effects 
and is less invasive than general anesthesia, it is not a process that is free of complica-
tions (Ridenour 1998). The purpose of using sedation during local anesthesia is to pro-
vide minimum anxiety/discomfort for patients.
During the surgery, sedation requirements change frequently depending on the stages 
of the operation. Intravenous sedative medications allow dosage adjustments in con-
scious patients. (Alhashemi and Kaki 2006) compared patient-controlled and anesthesi-
ologist-controlled sedation, and found that during the latter, more medication was used, 
sedation was deeper and recovery time was longer. In addition, patient-controlled seda-
tion allows ease of control of the depth of sedation and helps provide minimum anxiety/
discomfort during surgery (Joo et al. 2001).
Nausea, vomiting and nasal bleeding are more frequent in patients undergoing gen-
eral anesthesia than in patients undergoing local anesthesia. Sufficient bleeding and pain 
control of the nasal septum improves patient cooperation and patient handling and as a 
consequence; patient satisfaction at the end of the surgery (Fedok et al. 2000). Two com-
monly used drugs for patient-controlled sedation are dexmedetomidine and propofol. 
Dexmedetomidine is an α2 adrenergic receptor (adrenoceptor) agonist which is used for 
its unique properties for sedation and analgesia during the perioperative period. Because 
of its potent sedative, analgesic, perioperative sympatholytic effects, reduced anesthetic 
demand and cardiovascular stabilizing effects, dexmedetomidine became the center of 
interest for many recent studies. In addition, it does not cause respiratory depression. 
Dexmedetomidine activates the receptors in the brain and spinal cord and causes hypo-
tension, bradycardia, sedation and analgesia (Gertler et al. 2001 Jan). On the other hand, 
propofol is a short-acting anesthetic with short half-life, controllable dose–effect power 
and stable elimination rate. Propofol is sedative and anxiolytic in low doses but hypnotic 
in high doses. It has low to no amnestic effects. Depending on the dosage and the injec-
tion rate, a 15–25  % decrease in systolic, diastolic and mean arterial pressure (MAP) 
occurs in healthy patients, which makes it a widely preferred agent in septoplastic sur-
gery. Nevertheless, propofol has no analgesic effect (Rajapakse et al. 2003; Köksal 2007; 
Janzen et al. 1999).
In this study, our aim was to compare the sedation level and analgesic demand of 
patient-controlled analgesia (PCA) using dexmedetomidine and propofol.
Methods
Trial design
After Hacettepe University Medical Research Ethics Committee approval and informed 
consent, 50 patients aged 18–50 years who were undergoing septoplastical surgery were 
included in this prospective, randomized, parallel-group clinical study. The study was 
conducted at Hacettepe University Hospital. A single surgeon operated all patients. 
Patients with advanced heart, lung and kidney diseases; heavy bronchial asthma; cardiac 
block; long-term opioid, sedative and β-blocker usage; obesity with body mass index 
(BMI) >35  kg/m2; and a history of allergic reaction to medications used in this study 
were excluded from the study.
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Randomization
The 50 patients were randomly assigned to two groups (allocation ratio 1:1). Randomiza-
tion was done by the envelope draw method. Patients were informed about the usage of 
PCA before the surgery. Standard monitorization (continuous electrocardiogram, non-
invasive blood pressure monitoring, pulse oximeter, capnography) was applied. Th vital 
signs of all patients were recorded every 5 min.
Intervention
A nasopharyngeal cotton tampon soaked in a solution of 0.25 % adrenaline (Adrenalin®; 
Biofarma, Turkey) was placed. During the procedure, 3–5 L/min O2 was provided to the 
patients via an oral cannula. Five minutes before the injection of a surgical local anes-
thetic, 1 mg midazolam (Dormicum®; Roche, Turkey) and 1 mcg/kg fentanyl (Fentanyl 
Citrate®; Abbott, North Chicago, USA) were applied intravenously.
Group I 1 mg midazolam and 1 mcg/kg fentanyl were applied 5 min before the applica-
tion of surgical local anesthetic injection. After the delivery of a loading dose of 0.5 mg/
kg propofol in 10 min (Propofol-Lipuro® 1 %; Braun, Melsungen, Germany), local anes-
thesia with 0.5 % prilocaine hydrochloride–epinephrine solution (Jetokain®; Adeka, Tur-
key) was applied by the surgeon. The sedation was sustained by a bolus dose of 0.2 mg/
kg and a continuous basal infusion dose of 0.5 mg/kg/h propofol.
Group II 1 mg midazolam and 1 mcg/kg fentanyl were applied 5 min before the sur-
gical local anesthetic injection. After the delivery of a loading dose of 1  mcg/kg dex-
medetomidine in 10 min (Precedex®; Hospira, Lake Forest, USA), local anesthesia with 
0.5 % prilocaine hydrochloride–epinephrine solution (Jetokain®) was applied by the sur-
geon. The sedation was sustained by a bolus dose of 0.05 µg/kg and a continuous basal 
infusion dose of 0.4 mcg/kg/h dexmedetomidine.
When sufficient analgesia could not been achieved [visual analogue score (VAS) >4)], 
1  mcg/kg fentanyl was added to both groups and the dose was recorded. In addition, 
nausea and vomiting were evaluated at the end of each operation.
Outcomes
The primary outcomes were patient satisfaction and analgesic demand. Patient satisfac-
tion was evaluated using two 4-point scales (1: bad; 4: very good): the visual analogue 
scale (VAS) and the verbal rating scale (VRS) postoperatively. Secondary outcomes were 
sedation level evaluated by the observer’s assessment of alertness/sedation (OAA/S) 
perioperatively.
Statistical analysis
All statistical analyses were performed with SPSS v. 22.0. Shapiro–Wilk test was used as 
normality test. Continuous variables were compared using Student’s t-test and Mann–
Whitney U-test when the data were not normally distributed. Categorical variables were 
compared using Pearson’s Chi squared test and Fisher’s exact test. For responses at dif-
ferent time points, percent changes were calculated according to baseline measurement. 
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These percent changes were compared using Mann–Whitney U-test for two groups. A 
p-value <0.05 was considered statistically significant. A sample size of 28 patients (14 in 
each group) was calculated as necessary to detect a 1.5 point difference in VAS scores 
(expected SD ± 1.5) with a power of 80 % and α error of 0.05. We decided to start with 
25 patients in each group in case some patients could be excluded due to intraoperative 
complications or need for general anesthesia.
Results
Of the 50 patients initially enrolled, 49 were finally included in our study. One patient 
who had been intubated after sedation protocol from the propofol group was not 
included. There was no statistically significant difference between the two groups in 
terms of BMI, gender or age (Table 1).
When Groups I and II were compared in terms of MAP, a significantly greater decrease 
in Group I was observed at 10 min postoperatively (p < 0.05). In other time points, the 
difference was not statistically significant (Table 2).
When Groups I and II were compared in terms of heart rate, a significantly greater 
decrease in Group I was observed at 20  min postoperatively (p  <  0.05). In other time 
points, the difference was not statistically significant (Table 3).
When Groups I and II were compared in terms of SpO2, a significantly greater decrease 
in Group I was observed at 30, 40, 50, 60 and 70 min postoperatively (p < 0.05). In other 
time points, the difference was not statistically significant (Table 4).
When Groups I and II were compared in terms of VRS scores, a significantly greater 
decrease in Group I was observed at 10, 30, 50, 60 and 70 min postoperatively (p < 0.05). 
At 40 min postoperatively, the difference was not statistically significant (Table 5).
Table 1 Demographic data of the study patients
x¯ Arithmetic average, SD standard deviation, BMI body mass index
Group I Group II p
x¯ (SD) Median (range) x¯ (SD) Median (range)
Age 30.08 (5.92) 29.50 (22–43) 27.40 (9.22) 25 (18–47) 0.067
BMI 22.85 (2.52) 22.16 (18.97–29.06) 21.45 (2.58) 21.48 (17.30–26.42) 0.061
Table 2 Mean arterial pressure in Group I and II
* There is a significant decrease in MAP at 10 min
Measurement time Group I Group II p
Median (range) Median (range)
Preoperative 95 (69–117) 94 (73–109) 0.36
10 min 74 (44–111) 80 (72–103) 0.02*
20 min 77 (57–92) 78 (68–107) 0.38
30 min 80 (54–103) 82 (65–102) 0.11
40 min 77 (51–121) 83 (68–103) 0.07
50 min 74 (52–97) 80 (66–101) 0.05
60 min 76 (54–108) 82 (67–99) 0.05
70 min 74 (52–110) 79 (64–93) 0.68
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When Groups I and II were compared in terms of OAA/S scores, a significantly 
greater decrease in Group I was observed at 20, 30, 40, 60 and 70 min postoperatively 
(p < 0.05). In other time points, the difference was not statistically significant (Table 6).
Compared to Group I, Group II showed a significantly greater decrease in VAS scores 
(p < 0.05) at 30 min postoperatively. In other time points, the difference was not statisti-
cally significant (Table 7).
When Groups I and II were compared in terms of total fentanyl dosage, Group I 
required significantly more doses than Group II (p < 0.05) (Table 8).
No statistically meaningful difference was observed in postoperative nausea and vom-
iting between the two groups (Tables 9, 10).
Table 3 Heart rate in Groups I and II
* Statistically significant
Measurement time Group I Group II p
Median (range) Median (range)
Preoperative 86 (61–105) 78 (63–100) 0.08
10 min 80 (57–91) 83 (67–108) 0.42
20 min 74 (53–89) 80 (63–95) 0.02*
30 min 77 (63–87) 80 (66–88) 0.06
40 min 75 (54–90) 75 (65–91) 0.90
50 min 76 (53–92) 76 (62–83) 0.56
60 min 78 (53–90) 78 (60–87) 0.49
70 min 80 (62–88) 75 (55–86) 0.06
Table 4 SpO2 in Groups I and II
* Statistically significant
Measurement time Group I Group II p
Median (range) Median (range)
Preoperative 99 (95–100) 98 (97–99) 0.08
10 min 98 (92–100) 98 (96–99) 0.99
20 min 98 (94–100) 99 (97–100) 0.15
30 min 96 (93–100) 98 (96–100) <0.01*
40 min 95 (93–99) 98 (96–100) <0.01*
50 min 95 (94–98) 99 (96–100) <0.01*
60 min 97 (92–100) 99 (97–100) <0.01*
70 min 98 (95–99) 99 (97–100) 0.01*
Table 5 Verbal rating scale scores in Groups I and II
* Statistically significant
Measurement time Group I Group II p
Median (range) Median (range)
10 min 0.0 (0.0–3.0) 0.0 (0.0–1.0) <0.01*
20 min 1.0 (0.0–3.0) 0.0 (0.0–2.0) <0.01*
30 min 0.5 (0.0–3.0) 0.0 (0.0–2.0) 0.01*
40 min 0.0 (0.0–3.0) 0.0 (0.0–2.0) 0.59
50 min 0.5 (0.0–2.0) 0.0 (0.0–2.0) <0.01*
60 min 1.0 (0.0–3.0) 0.0 (0.0–2.0) <0.01*
70 min 0.0 (0.0–4.0) 0.0 (0.0–2.0) 0.51
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Discussion
In this study, we compared dexmedetomidine and propofol in terms of sedation, analgesic 
demand, and patient satisfaction via PCA in 50 patients who underwent septoplastic sur-
gery. We observed that dexmedetomidine provided enough sedation and analgesic levels 
Table 6 Observer’s assessment of  alertness/sedation (OAA/S) scale scores in  Groups I 
and II
* Statistically significant
Measurement time Group I Group II p
Median (range) Median (range)
10 min 5 (3–5) 5 (3–5) 0.69
20 min 5 (3–5) 5 (3–5) 0.03*
30 min 5 (2–5) 5 (5–5) <0.01*
40 min 5 (3–5) 5 (5–5) <0.01*
50 min 5 (3–5) 5 (4–5) 0.17
60 min 5 (3–5) 5 (5–5) <0.01*
70 min 5 (4–5) 5 (5–5) 0.03*
Table 7 Visual analogue scale scores in Groups I and II
* Statistically significant
Measurement time Group I Group II p
Median (range) Median (range)
30 min 5 (1–7) 4 (1–6) 0.01*
60 min 4 (0–8) 3 (0–5) 0.12
120 min 1 (0–7) 2 (0–4) 0.98
Table 8 Total fentanyl dosage in Groups I and II
* Statistically significant
Group I Group II p
Median (range) Median (range)
Total 225 (150–300) 45 (25–50) <0.01*
Table 9 Frequency of postoperative nausea in Groups I and II
Measurement time Group I (%) Group II (%) p
30 min 8.3 20.0 0.417
60 min 12.5 20.0 0.702
120 min 12.5 8.0 0.667
Table 10 Frequency of postoperative vomiting in Groups I and II
Measurement time Group I (%) Group II (%) p
30 min 0 4 1.000
60 min 8.3 4 0.609
120 min 8.3 4 0.609
Page 7 of 9Akça et al. SpringerPlus  (2016) 5:572 
without causing respiratory depression. We also found that compared to propofol, dexme-
detomidine provided stable hemodynamics and satisfactory sedation while reducing the 
need for additional anesthesia by decreasing the requirement for intraoperative fentanyl. 
No statistically significant difference was observed in postoperative patient satisfaction.
When it is applied by experienced surgeons, septoplasty is mostly a daily operation 
owing to the short duration of surgery and easy postoperative care (Ridenour 1998). 
Because of the innervational characteristics of the septum, a good intraoperative hem-
orrhage control and an effective postoperative analgesia requirement is highly recom-
mended (Alhashemi and Kaki 2006).
Discussions are still continuing whether septoplasty should be applied under general 
anesthesia or local anesthesia with sedation. Obtaining surgical analgesia and amnesia 
without requiring an airway instrumentation and with short hospital stays are the big-
gest advantages of local anesthesia with sedation (Joo et al. 2001). In a study by Fedok 
and colleagues that included 177 nasal septoplasty and endoscopic sinus surgery 
patients, total surgery time, recovery unit and discharge from the hospital were shorter 
in the local anesthesia with sedation group than in the general anesthesia group Fedok 
et  al. (2000). In addition, the frequency of postoperative nausea and epistaxis was 
higher in the general anesthesia group (Fedok et al. 2000). In another study including 
197 nasal fracture patients, subjective patient assessments were significantly better in 
the local anesthesia with sedation group; 69 % of those patients stated that they would 
accept to be operated on a second time using the same method (Rajapakse et al. 2003).
Many different drugs (e.g., propofol, benzodiazepines and opioids) are used to pro-
vide sedation in septoplasty. Among them, propofol is associated with complications 
such as delayed surgery or hospitalization, especially in elderly patients (Köksal 2007; 
Janzen et al. 1999; Weinbroum et al. 2001; Wong and Merrick 1996). Myoclonus, mus-
cle twitch and hiccups are also among the known side effects of propofol use. In our 
study, although myoclonus, muscle twitch, and hiccups were not observed, 41.6 % of the 
patients stated having pain on the back of the hand at the site of propofol injection. A 
patient in the propofol group required intubation because of apnea development and 
insufficient anesthesia. Additionally, oxygen saturation values were lower in this group 
than the dexmedetomidine group, but these values were not statistically significant 
Thus, patients using propofol need to be monitored closely, and additional analgesic 
medication is often required even during PCA (Salmon et al. 1992; Sebel and Lowdon 
1989; Peacock et al. 1990; Grounds et al. 1987; Duke 2006). In our study, unlike propofol, 
dexmedetomidine promoted the desired sedation levels. No respiratory depression was 
observed when additional analgesic (an opioid) was required.
Uzumcugil and colleagues compared propofol–fentanyl and dexmedetomidine infu-
sion for laryngeal mask airway insertion and found that dexmedetomidine provided 
more stable hemodynamics in geriatric patients (Uzümcügil et al. 2008). In our study, 
postoperative MAP values were significantly lower than preoperative values in both 
groups. Clinically, the decrease in MAP was not important and it was within the desired 
levels for hypotensive anesthesia, which is required for septoplastic surgeries. In the 
propofol group, the heart rate at 20 min was lower than in the dexmedetomidine group. 
These low values were statistically significant, yet were not clinically within bradycardia 
border limits, thus not requiring any intervention.
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In our study, at 30, 40, 50, 60 and 70 min postoperatively, the SpO2 values were lower 
in propofol group than in the dexmedetomidine group. The decrease at these saturation 
levels was not deep enough to pose any clinical risk. In other words, no clinically desatu-
ration developed in either group. Only one patient in the propofol group required intu-
bation due to apnea, and was excluded from the study right after intubation. In another 
study performed by Kenan and his colleagues, comparing dexmedetomidine and propo-
fol in ESWL, SpO2 values were significantly higher (Kaygusuz et al. 2008). In the same 
study, although dexmedetomidine lowered the respiratory rate compared to propofol, 
SpO2 values in the dexmedetomidine group were higher. The authors attributed these 
results to propofol causing minimal decrease in respiratory rate and tidal volume at sed-
ative dosage. We suggest that the higher oxygen saturation values in the dexmedetomi-
dine group might be associated to respiratory depression effect of propofol as well as 
high fentanyl requirement for analgesia (Kaygusuz et al. 2008; Hall et al. 2000).
Turgut and colleagues significantly higher postoperative additional analgesic require-
ment for the fentanyl group than for the dexmedetomidine group (Turgut et al. 2008). 
In another study by Kenan and colleagues in which sedation with dexmedetomidine 
and propofol was compared in ESWL, VAS values in the dexmedetomidine group at 25 
and 35 min were significantly lower than in the propofol group. Dexmedetomidine was 
found to be better than propofol for providing sedation and analgesia (Kaygusuz et al. 
2008). In our study, when intraoperative VRS, postoperative VAS values and analgesic 
effectiveness were compared, statistically significant lower values were observed in the 
dexmedetomidine group than in the propofol group at 10, 20, 30, 50, 60 and 70  min. 
Postoperative VAS at 30 min was significantly lower in the dexmedetomidine group than 
in the propofol group. The results are similar to those found in the literature.
Turgut and his colleagues showed that nausea and vomiting were statistically higher 
in the fentanyl group (Turgut et al. 2008). In the study conducted by Koroglu and col-
leagues, propofol and dexmedetomidine were compared in MRI of children and neither 
nausea nor vomiting was reported (Koroglu et al. 2006). Kenan and colleagues compared 
dexmedetomidine and propofol in ESWL procedure. 2 patients in dexmedetomidine 
and 5 patients in propofol group reported having nausea, only 2 patients in propofol 
group vomited, yet with no statistically significant difference (Kaygusuz et al. 2008). In 
our study, in accordance to other studies, no statistically significant difference was found 
between propofol and dexmedetomidine groups in nausea and vomiting incidence. We 
attributed this result to the antiemetic properties of propofol at sub-hypnotic doses 
(Turgut et al. 2008), although more fentanyl was applied.
The sedation level required to tolerate the operation by the patients may be different 
than the sedation level provided by the anesthesiologist. During the surgery, sedation 
requirements change constantly.
Conclusion
In our study dexmedetomidine provided adequate intraoperative analgesia as well as 
satisfactory sedation without suppressing respiration. In terms of postoperative patient 
satisfaction, both dexmedetomidine and propofol were similar. Therefore, dexmedeto-
midine can be safely used as a sedative agent via PCA in patients having surgery under 
local anesthesia with sedation.
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